Chicago / Edinburgh
THE IPOX® NEWSLETTERS

The IPOX® Update archive

Our weekly summary of news and developments across global IPO markets.

248 editions

The IPOX® Update 3/21/2025

The IPOX® Update highlights major upcoming public offerings across global markets. Leading the pack is CoreWeave's $2.7B Nasdaq listing alongside significant deals from Klarna ($1B+), Ukraine's Kyivstar ($2.2B), and Hinge Health ($500M). The report covers 13 companies preparing to go public across the U.S., Europe, and Asia-Pacific regions, with detailed insights on valuations, timing, and market challenges.

Read edition

The IPOX® Update 3/15/2025

AI and health tech lead March's IPO surge with CoreWeave securing a $12B OpenAI contract ahead of its New York debut, while Hinge Health files to raise $500M. The pipeline remains robust across regions with StubHub targeting $1B+ in the US, South Korea's DN Solutions seeking $1B in Seoul, and Air Baltic planning a London listing. MENA markets show strength with Umm Al Qura's offering attracting over $1B from retail investors alone, while China's tech sector sees renewed listing momentum.

Read edition

The IPOX® Update 3/8/2025

AI-powered CoreWeave targets $4B raise at $35B valuation, while fintech giant Klarna prepares $1B+ New York debut. Tech dominates upcoming listings with cryptocurrency exchanges Gemini and Kraken, design platform Figma, and communications app Discord all planning 2025 offerings. Europe and Asia-Pacific markets see continued activity with healthcare, finance and industrial firms leading the charge.

Read edition

The IPOX® Update 3/1/2025

Global IPO activity is spread across regions. In the U.S., CoreWeave and Holcim's Amrize are planning major listings. Europe sees Olam Food Ingredients gearing up for a London IPO and Northern Data for Frankfurt uplisting. Asia-Pacific is vibrant with Mixue's Hong Kong IPO seeing huge demand and JX Advanced Metals launching a large Tokyo IPO. Saudi Arabia's Umm Al Qura IPO in MENA was heavily oversubscribed, showcasing diverse IPO opportunities globally.

Read edition

The IPOX® Update 2/22/2025

Global IPO markets are active with diverse listings planned across regions. Hong Kong anticipates large offerings from Kayou ($500M) and Mixue ($443M), while Malaysia's Eco-Shop eyes $212M. Oman's Asyad Shipping targets $333M, and Abu Dhabi's Alpha Data, $163M. Saudi Arabia expects a record IPO year. In the US, Redcloud revives a smaller offering. Europe sees potential listings from Swedish SBB and German OLB, with Shein considering London amidst valuation pressures. Singapore aims to attract Chinese listings.

Read edition

The IPOX® Update 2/14/2025

Global IPO activity is high, especially in the US with Klarna's potential $15B IPO. Asia-Pacific is highlighted by JX Advanced Metal's potential record $3B Japan IPO and Mixue's $500M HK listing. Europe sees Novo Banco's €5B IPO and London vying for listings like IVC Evidensia and CurrentBody.

Read edition

The IPOX® Update 2/7/2025

Robust global IPO activity across multiple sectors: Significant US listings include SailPoint, projecting an $11.5B valuation, and DailyPay, targeting $3-4B. Honeywell's planned spin-offs represent a notable corporate restructuring. European markets are active, featuring Novo Banco and CurrentBody. In Asia, MMC Port's anticipated $1.34B Malaysian IPO highlights the region's strength. The Middle East maintains a positive outlook, with Saudi Arabia driving deal flow.

Read edition

The IPOX® Update 2/1/2025

Large potential IPOs are emerging across regions. In the US, Silvus considers a $5B valuation IPO, while Histosonics aims for a multi-billion dollar valuation. SailPoint eyes a $1B Nasdaq return. Europe sees EcoCeres planning a $5B IPO and HBX Group with strong book coverage for its Amsterdam listing.

Read edition

The IPOX® Update 1/25/2025

US IPO market shows signs of heating up in early 2025 with notable confidential filings like Voyager Technologies in space and defense ($2-3B valuation). Odyssey Therapeutics (biotech), SailPoint (cybersecurity), and Metsera (obesity drugs) have also filed for IPOs on Nasdaq. While January saw a slow start, NYSE anticipates a robust IPO market recovery driven by a strong economy and potentially lower interest rates, suggesting a positive outlook for US listings in the coming months.

Read edition
THE IPOX® NEWSLETTERS

Stay ahead of the next listing.

Research and insight from the global new listings market.

Explore our newsletters